When a heart stops beating, blood stops flowing and delivering oxygen to the brain (hypoxia) and other vital organs (ischemia). There is a small window (about 4 minutes) before the lack of blood flow begins to damage the ...
For patients with sudden sensorineural hearing loss (SSNHL), vestibular assessment is beneficial for predicting hearing outcome, according to a study published online Feb. 15 in the Frontiers of Neurology.
Mar 24, 2023
0
13
A good night's sleep is essential for good health, but many Latinos in the U.S. just don't get enough of it.
Mar 24, 2023
0
3
A bone marrow transplant can be a lifesaving treatment for people with relapsed blood cancers, but a potentially lethal complication known as graft-versus-host disease put limitations on this procedure. New research from ...
Mar 24, 2023
0
43
Your circadian rhythm doesn't just govern your sleeping schedule; it can also impact cancer development, diagnosis, and treatment. In a review paper published in the journal Trends in Cell Biology, researchers discuss the ...
Mar 24, 2023
0
114
Hemostasis is vital to prevent excessive blood loss. However, there is an increased risk for thrombosis if there is an excessive reaction and uncontrolled formation of fibrin. In a new study published in Nature Cardiovascular ...
Mar 24, 2023
0
15
A machine learning model has been proven effective as a decision-support tool for dispatchers of Emergency Medical Services (EMS), resulting in improved triage quality and ambulance utilization, according to a study done ...
Mar 24, 2023
0
5
Type 2 diabetes is a chronic disease in which the body does not produce enough insulin, or does not use it efficiently. It is caused by the combination of a genetic predisposition to obesity, sedentarism and an unhealthy ...
Mar 23, 2023
0
22
The origin of SARS-CoV-2, the virus that causes COVID, has long been a topic of heated debate. While many believe SARS-CoV-2 spread to humans from an animal at Wuhan's Huanan Wholesale Seafood Market, others have argued the ...
Mar 23, 2023
0
8
Researchers at Texas A&M; University have developed the first molecular therapeutic for Angelman syndrome to advance into clinical development.
Mar 23, 2023
0
78
